Takotsubo syndrome after treatment with non-cardiotoxic chemotherapy agents

Basit Öğe Kaydı
dc.contributor.authorŞimşek, Evrim
dc.contributor.authorKültürsay, Hakan
dc.contributor.authorKemal, Hatice
dc.contributor.authorGürses, Ecem
dc.contributor.authorÖzbay, Benay
dc.date.accessioned2023-01-12T20:36:43Z
dc.date.available2023-01-12T20:36:43Z
dc.date.issued2021
dc.departmentN/A/Departmenten_US
dc.description.abstractSummary– Takotsubo syndrome (TTS), acute stress-induced cardiomyopathy, is known to have a dramatic clinical presentation mimicking acute myocardial infarction. Recently developed chemotherapeutic drugs have resulted in improvements in morbidity and mortality in many forms of cancer. However, some chemotherapeutic drugs are cardiotoxic and may cause heart failure. Gemcitabine and vinorelbine are commonly used drugs for various solid organ neoplasms. While neither of these chemotherapeutic drugs has been directly associated with cardiotoxicity, there are a few case reports in the literature related to gemcitabine treatment-induced cardiomyopathy. This case report describes a case of TTS developing within hours of gemcitabine and vinorelbine chemotherapy.en_US
dc.identifier.doi10.5543/tkda.2020.25590
dc.identifier.endpage75en_US
dc.identifier.issn1016-5169
dc.identifier.issn1308-4488
dc.identifier.issue1en_US
dc.identifier.startpage72en_US
dc.identifier.trdizinid484839en_US
dc.identifier.urihttps://doi.org/10.5543/tkda.2020.25590
dc.identifier.urihttps://search.trdizin.gov.tr/yayin/detay/484839
dc.identifier.urihttps://hdl.handle.net/11454/81383
dc.identifier.volume49en_US
dc.indekslendigikaynakTR-Dizinen_US
dc.language.isoenen_US
dc.relation.ispartofTürk Kardiyoloji Derneği Arşivien_US
dc.relation.publicationcategoryMakale - Ulusal Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.titleTakotsubo syndrome after treatment with non-cardiotoxic chemotherapy agentsen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

TR-Dizin İndeksli Yayınlar Koleksiyonu